|
1
|
Alam M and Ratner D: Cutaneous
squamous-cell carcinoma. N Engl J Med. 344:975–983. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ratushny V, Gober MD, Hick R, Ridky TW and
Seykora JT: From keratinocyte to cancer: the pathogenesis and
modeling of cutaneous squamous cell carcinoma. J Clin Invest.
122:464–472. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bushati N and Cohen SM: MicroRNA
functions. Annu Rev Cell Dev Biol. 23:175–205. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang S and He X: The role of microRNAs in
liver cancer progression. Br J Cancer. 104:235–240. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kent OA and Mendell JT: A small piece in
the cancer puzzle: microRNAs as tumor suppressors and oncogenes.
Oncogene. 25:6188–6196. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Acunzo M, Romano G, Wernicke D and Croce
CM: MicroRNA and cancer - A brief overview. Adv Biol Regul. 57:1–9.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ,
Hwang SY, Kim WY, Kim TJ, Lee JH, Kim BG and Bae DS: Altered
MicroRNA expression in cervical carcinomas. Clin Cancer Res.
14:2535–2542. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bruegger C, Kempf W, Spoerri I, Arnold AW,
Itin PH and Burger B: MicroRNA expression differs in cutaneous
squamous cell carcinomas and healthy skin of immunocompetent
individuals. Exp Dermatol. 22:426–428. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sand M, Skrygan M, Georgas D, Sand D, Hahn
SA, Gambichler T, Altmeyer P and Bechara FG: Microarray analysis of
microRNA expression in cutaneous squamous cell carcinoma. J
Dermatol Sci. 68:119–126. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou M, Liu W, Ma S, Cao H, Peng X, Guo L,
Zhou X, Zheng L, Guo L, Wan M, et al: A novel onco-miR-365 induces
cutaneous squamous cell carcinoma. Carcinogenesis. 34:1653–1659.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang A, Landén NX, Meisgen F,
Lohcharoenkal W, Ståhle M, Sonkoly E and Pivarcsi A: MicroRNA-31 is
overexpressed in cutaneous squamous cell carcinoma and regulates
cell motility and colony formation ability of tumor cells. PLoS
One. 9:e1032062014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gastaldi C, Bertero T, Xu N,
Bourget-Ponzio I, Lebrigand K, Fourre S, Popa A, Cardot-Leccia N,
Meneguzzi G, Sonkoly E, et al: MiR-193b/365a cluster controls
progression of epidermal squamous cell carcinoma. Carcinogenesis.
35:1110–1120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et
al: Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang L, Lin JX, Yu YH, Zhang MY, Wang HY
and Zheng M: Downregulation of six microRNAs is associated with
advanced stage, lymph node metastasis and poor prognosis in small
cell carcinoma of the cervix. PLoS One. 7:e337622012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shen Q, Cicinnati VR, Zhang X, Iacob S,
Weber F, Sotiropoulos GC, Radtke A, Lu M, Paul A, Gerken G and
Beckebaum S: Role of microRNA-199a-5p and discoidin domain receptor
1 in human hepatocellular carcinoma invasion. Mol Cancer.
9:2272010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu N, Zhang J, Shen C, Luo Y, Xia L, Xue F
and Xia Q: Cisplatin-induced downregulation of miR-199a-5p
increases drug resistance by activating autophagy in HCC cell.
Biochem Biophys Res Commun. 423:826–831. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
He XJ, Ma YY, Yu S, Jiang XT, Lu YD, Tao
L, Wang HP, Hu ZM and Tao HQ: Up-regulated miR-199a-5p in gastric
cancer functions as an oncogene and targets klotho. BMC cancer.
14:2182014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu Y, Liu J, Jiang B, Chen J, Fu Z, Bai F,
Jiang J and Tang Z: MiR-199a-5p loss up-regulated DDR1 aggravated
colorectal cancer by activating epithelial-to-mesenchymal
transition related signaling. Dig Dis Sci. 59:2163–2172. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Barrette K, Van Kelst S, Wouters J,
Marasigan V, Fieuws S, Agostinis P, van den Oord J and Garmyn M:
Epithelial-mesenchymal transition during invasion of cutaneous
squamous cell carcinoma is paralleled by AKT activation. Br J
Dermatol. 171:1014–1021. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Balch CM, Gershenwald JE, Soong SJ,
Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG,
Ding S, et al: Final version of 2009 AJCC melanoma staging and
classification. J Clin Oncol. 27:6199–6206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tanemura A, Terando AM, Sim MS, van Hoesel
AQ, de Maat MF, Morton DL and Hoon DS: CpG island methylator
phenotype predicts progression of malignant melanoma. Clin Cancer
Res. 15:1801–1807. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu N, Zhang L, Meisgen F, Harada M,
Heilborn J, Homey B, Grandér D, Ståhle M, Sonkoly E and Pivarcsi A:
MicroRNA-125b down-regulates matrix metallopeptidase 13 and
inhibits cutaneous squamous cell carcinoma cell proliferation,
migration and invasion. J Biol Chem. 287:29899–29908. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nelson WJ and Nusse R: Convergence of Wnt,
beta-catenin and cadherin pathways. Science. 303:1483–1487. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Deng QW, He BS, Pan YQ, Sun HL, Xu YQ, Gao
TY, Li R, Song GQ and Wang SK: Roles of E-cadherin (CDH1) genetic
variations in cancer risk: a meta-analysis. Asian Pac J Cancer
Prev. 15:3705–3713. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shimada Y, Hashimoto Y, Kan T, Kawamura J,
Okumura T, Soma T, Kondo K, Teratani N, Watanabe G, Ino Y, et al:
Prognostic significance of dysadherin expression in esophageal
squamous cell carcinoma. Oncology. 67:73–80. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Toll A, Masferrer E, Hernández-Ruiz ME,
Ferrandiz-Pulido C, Yébenes M, Jaka A, Tuneu A, Jucglà A, Gimeno J,
Baró T, et al: Epithelial to mesenchymal transition markers are
associated with an increased metastatic risk in primary cutaneous
squamous cell carcinomas but are attenuated in lymph node
metastases. J Dermatol Sci. 72:93–102. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Brouxhon SM, Kyrkanides S, Raja V,
Silberfeld A, Teng X, Trochesset D, Cohen J and Ma L:
Ectodomain-specific E-cadherin antibody suppresses skin SCC growth
and reduces tumor grade: a multitargeted therapy modulating RTKs
and the PTEN-p53-MDM2 axis. Mol Cancer Ther. 13:1791–1802. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jiang J, Gusev Y, Aderca I, Mettler TA,
Nagorney DM, Brackett DJ, Roberts LR and Schmittgen TD: Association
of MicroRNA expression in hepatocellular carcinomas with hepatitis
infection, cirrhosis and patient survival. Clin Cancer Res.
14:419–427. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Peng W, Chen ZY, Wang L, Wang Z and Li J:
MicroRNA-199a-3p is downregulated in gastric carcinomas and
modulates cell proliferation. Genet Mol Res. 12:3038–3047. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liang Y, Ridzon D, Wong L and Chen C:
Characterization of microRNA expression profiles in normal human
tissues. BMC Genomics. 8:1662007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhao X, He L, Li T, Lu Y, Miao Y, Liang S,
Guo H, Bai M, Xie H, Luo G, et al: SRF expedites metastasis and
modulates the epithelial to mesenchymal transition by regulating
miR-199a-5p expression in human gastric cancer. Cell Death Differ.
21:1900–1913. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ryzhakova OS and Solov'eva NI: Matrix
metalloproteinases (MMP)-MMP-1,-2,-9 and its endogenous activity
regulators in transformed by E7 oncogene HPV16 and HPV18 cervical
carcinoma cell lines. Biomed Khim. 59:530–540. 2013.(In Russian).
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mohtasham N, Babakoohi S, Shiva A, Shadman
A, Kamyab-Hesari K, Shakeri MT and Sharifi-Sistani N:
Immunohistochemical study of p53, Ki-67, MMP-2 and MMP-9 expression
at invasive front of squamous cell and verrucous carcinoma in oral
cavity. Pathol Res Pract. 209:110–114. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Burduk PK, Bodnar M, Sawicki P, Szylberg
Ł, Wiśniewska E, Kaźmierczak W, Martyńska M and Marszałek A:
Expression of metalloproteinases 2 and 9 and tissue inhibitors 1
and 2 as predictors of lymph node metastases in oropharyngeal
squamous cell carcinoma. Head Neck. 37:418–422. 2015. View Article : Google Scholar : PubMed/NCBI
|
